ClinicalTrials.Veeva

Menu

Frailty, Hip Fractures and Inflammatory Biomarkers

U

University of Thessaly

Status

Enrolling

Conditions

Hip Fracture
Frailty
Inflammatory Biomarkers

Study type

Observational

Funder types

Other

Identifiers

NCT06614478
Frailty and hip fractures

Details and patient eligibility

About

We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.

Full description

Frailty (F) is a prevalent syndrome among elderly patient with hip fractures (HF) and has been linked to poor prognosis. Inflammatory biomarkers have been used as prognostic indexes in patients with HF. We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.

Enrollment

200 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age >65 years, ASA PS I-III, non- institutionalized, able to communicate patients

Exclusion criteria

  • Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate

Trial design

200 participants in 1 patient group

hip fracture patients treated with surgery
Description:
Hip fracture patients treated with surgery. Frailty will be categorized based on the validated Groningen Frailty Indicator (GFI)

Trial contacts and locations

2

Loading...

Central trial contact

Maria Ntalouka, MD, PhD, Mac; Eleni Arnaoutoglou, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems